A detailed history of Sterling Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sterling Investment Management, LLC holds 16,001 shares of ABBV stock, worth $3.02 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares
16,001
Previous 20,174 20.69%
Holding current value
$3.02 Million
Previous $3.67 Million 25.29%
% of portfolio
2.18%
Previous 2.71%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $645,938 - $754,311
-4,173 Reduced 20.69%
16,001 $2.74 Million
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $46,187 - $52,626
-289 Reduced 1.41%
20,174 $3.67 Million
Q4 2023

Jan 17, 2024

SELL
$137.6 - $154.97 $61,232 - $68,961
-445 Reduced 2.13%
20,463 $3.17 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $47,424 - $54,900
-355 Reduced 1.67%
20,908 $3.12 Million
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $37,102 - $46,172
-280 Reduced 1.3%
21,263 $2.86 Million
Q1 2023

Apr 27, 2023

SELL
$144.61 - $166.54 $48,588 - $55,957
-336 Reduced 1.54%
21,543 $3.43 Million
Q4 2022

Jan 12, 2023

SELL
$138.31 - $165.87 $212,029 - $254,278
-1,533 Reduced 6.55%
21,879 $0
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $435,108 - $499,041
3,242 Added 16.07%
23,412 $3.14 Million
Q2 2022

Jul 06, 2022

SELL
$137.62 - $174.96 $92,205 - $117,223
-670 Reduced 3.21%
20,170 $3.09 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $660,691 - $819,732
-5,006 Reduced 19.37%
20,840 $3.38 Million
Q4 2021

Jan 21, 2022

SELL
$107.43 - $135.93 $50,706 - $64,158
-472 Reduced 1.79%
25,846 $3.5 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $556,578 - $631,800
5,231 Added 24.81%
26,318 $2.84 Million
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $768,138 - $855,750
-7,301 Reduced 25.72%
21,087 $2.38 Million
Q1 2021

Apr 19, 2021

SELL
$102.3 - $112.62 $97,287 - $107,101
-951 Reduced 3.24%
28,388 $3.07 Million
Q4 2020

Jan 22, 2021

SELL
$80.49 - $108.67 $225,452 - $304,384
-2,801 Reduced 8.71%
29,339 $3.14 Million
Q3 2020

Oct 28, 2020

BUY
$85.91 - $100.83 $1.1 Million - $1.29 Million
12,747 Added 65.73%
32,140 $2.82 Million
Q2 2020

Jul 14, 2020

BUY
$73.37 - $98.18 $807,730 - $1.08 Million
11,009 Added 131.31%
19,393 $1.9 Million
Q1 2020

Apr 22, 2020

BUY
$64.5 - $97.79 $540,768 - $819,871
8,384 New
8,384 $639,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $333B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sterling Investment Management, LLC Portfolio

Follow Sterling Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Management, LLC with notifications on news.